Metabolic antianginal agent ranolazine offers good symptom relief in a patient with inoperable severe aortic stenosis

Pandula Athauda-arachchi; Chim Lang

doi:10.1111/j.1755-5922.2011.00273.x

Metabolic antianginal agent ranolazine offers good symptom relief in a patient with inoperable severe aortic stenosis

Pandula Athauda-arachchi
, Chim Lang

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

Abstract

Severe inoperable aortic stenosis is a challenge for clinicians. Management of symptoms with traditional antianginal agents, which exert hemodynamic changes often may not be possible in such patient groups. We report the first known case of the safe use of Ranolazine with good symptomatic relief of angina in an 88-year-old lady with isolated severe aortic stenosis (without significant coronary disease) who was not suitable for surgical or percutaneous valve replacement due to medical comorbidity.

Original language	English
Journal	Cardiovascular Therapeutics
DOIs	https://doi.org/10.1111/j.1755-5922.2011.00273.x
Publication status	Published - 2011

Access to Document

10.1111/j.1755-5922.2011.00273.x

Cite this

@article{2683ed6653c547a190705a587da3c445,

title = "Metabolic antianginal agent ranolazine offers good symptom relief in a patient with inoperable severe aortic stenosis",

abstract = "Severe inoperable aortic stenosis is a challenge for clinicians. Management of symptoms with traditional antianginal agents, which exert hemodynamic changes often may not be possible in such patient groups. We report the first known case of the safe use of Ranolazine with good symptomatic relief of angina in an 88-year-old lady with isolated severe aortic stenosis (without significant coronary disease) who was not suitable for surgical or percutaneous valve replacement due to medical comorbidity.",

author = "Pandula Athauda-arachchi and Chim Lang",

year = "2011",

doi = "10.1111/j.1755-5922.2011.00273.x",

language = "English",

journal = "Cardiovascular Therapeutics",

issn = "1755-5914",

publisher = "John Wiley and Sons Inc",

}

TY - JOUR

T1 - Metabolic antianginal agent ranolazine offers good symptom relief in a patient with inoperable severe aortic stenosis

AU - Athauda-arachchi, Pandula

AU - Lang, Chim

PY - 2011

Y1 - 2011

N2 - Severe inoperable aortic stenosis is a challenge for clinicians. Management of symptoms with traditional antianginal agents, which exert hemodynamic changes often may not be possible in such patient groups. We report the first known case of the safe use of Ranolazine with good symptomatic relief of angina in an 88-year-old lady with isolated severe aortic stenosis (without significant coronary disease) who was not suitable for surgical or percutaneous valve replacement due to medical comorbidity.

AB - Severe inoperable aortic stenosis is a challenge for clinicians. Management of symptoms with traditional antianginal agents, which exert hemodynamic changes often may not be possible in such patient groups. We report the first known case of the safe use of Ranolazine with good symptomatic relief of angina in an 88-year-old lady with isolated severe aortic stenosis (without significant coronary disease) who was not suitable for surgical or percutaneous valve replacement due to medical comorbidity.

UR - https://www.scopus.com/pages/publications/84863445721

U2 - 10.1111/j.1755-5922.2011.00273.x

DO - 10.1111/j.1755-5922.2011.00273.x

M3 - Letter

C2 - 21884008

SN - 1755-5914

JO - Cardiovascular Therapeutics

JF - Cardiovascular Therapeutics

ER -

Metabolic antianginal agent ranolazine offers good symptom relief in a patient with inoperable severe aortic stenosis

Abstract

Access to Document

Other files and links

Fingerprint

Cite this